KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Common Equity (2016 - 2025)

Historic Common Equity for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $26.5 billion.

  • Eli Lilly's Common Equity rose 8592.35% to $26.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $26.5 billion, marking a year-over-year increase of 8592.35%. This contributed to the annual value of $26.5 billion for FY2025, which is 8592.35% up from last year.
  • Per Eli Lilly's latest filing, its Common Equity stood at $26.5 billion for Q4 2025, which was up 8592.35% from $23.9 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Common Equity ranged from a high of $26.5 billion in Q4 2025 and a low of $6.7 billion during Q2 2021
  • For the 5-year period, Eli Lilly's Common Equity averaged around $12.7 billion, with its median value being $11.2 billion (2023).
  • Per our database at Business Quant, Eli Lilly's Common Equity surged by 12204.74% in 2021 and then skyrocketed by 81.95% in 2023.
  • Over the past 5 years, Eli Lilly's Common Equity (Quarter) stood at $9.2 billion in 2021, then grew by 17.7% to $10.8 billion in 2022, then rose by 0.82% to $10.9 billion in 2023, then skyrocketed by 31.37% to $14.3 billion in 2024, then skyrocketed by 85.92% to $26.5 billion in 2025.
  • Its Common Equity stands at $26.5 billion for Q4 2025, versus $23.9 billion for Q3 2025 and $18.3 billion for Q2 2025.